Patent Assignment
Reel/Frame 071913/0691
Security Interest
Recorded: 2025-08-01
Pages: 10
Assignors
STRATATECH CORPORATION
Executed: 2025-08-01
SUCAMPO PHARMA AMERICAS LLC
Executed: 2025-08-01
VTESSE LLC
Executed: 2025-08-01
Assignee
COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
1505 ENERGY PARK DRIVE, ST. PAUL, MINNESOTA, 55108
Covered Properties
(40)
Method for Manufacturing Prostaglandin Analogue
Method for Treating Gastrointestinal Disorder
Human skin equivalents expressing exogenous polypeptides
Skin substitutes with improved purity
Soft-Gelatin Capsule Formulation
Pharmaceutical Composition Comprising a Bi-Cyclic Compound and Method for Stabilizing the Bi-Cyclic Compound
Method for Preparing 15-Keto-Prostaglandin E Derivative
Method for Preparing Prostaglandin Derivative
Method for Promoting Gastrointestinal Bicarbonate Secretion
Dried and Irradiated Skin Equivalents for Ready Use
Method for Preparing Prostaglandin Derivative
Method for Preparing Prostaglandin Derivative
Method for Preparing Prostaglandin Derivative
Facilitating Noise Estimation in Wireless Communication
Method for Promoting Upper Gastrointestinal Bicarbonate Secretion
Pharmaceutical Composition Comprising a Bi-Cyclic Compound and Method for Stabilizing the Bi-Cyclic Compound
Soft-Gelatin Capsule Formulation
Method for Preparing a Fatty Acid Derivative
Soft-Gelatin Capsule Formulation
Use of Delta Tocopherol for the Treatment of Lysosomal Storage Disorders
Dried and Irradiated Skin Equivalents for Ready Use
Cryopreservation of Viable Human Skin Substitutes
Dried and Irradiated Skin Equivalents for Ready Use
Dried and Irradiated Skin Equivalents for Ready Use
Use of Delta Tocopherol for the Treatment of Lysosomal Storage Disorders
Cold Storage of Organotypically Cultured Skin Equivalents for Clinical Applications
Dried and Irradiated Skin Equivalents for Ready Use
Pharmaceutical Combination of Opioid and Prostaglandin Compound
Cryopreservation of Viable Human Skin Substitutes
Use of Human Skin Substitutes Expressing Exogenous Il-12 to Treat a Wound Bed
Multilayer Beads for Pharmaceutical Use
Tissue Container Systems
Cryopreservation of Viable Human Skin Substitutes
Application:
17/694,245 →
Publication:
US 2022/0192181
Methods for Treating Acute Wounds and Improving Outcomes
Application:
17/763,552 →
Publication:
US 2022/0347353
Tissue Container Systems
Application:
17/827,270 →
Publication:
US 2022/0287298
Engineered Skin Construct Overlay of Autograft
Application:
18/014,951 →
Publication:
US 2023/0330153
Methods for Priming Allogeneic Cultured Keratinocyte Compositions for Topical Use
Application:
18/565,003 →
Publication:
US 2024/0245729
Tissue Container Systems
Application:
18/565,005 →
Publication:
US 2024/0245050
Allogeneic Cultured Keratinocyte Products
Application:
18/565,007 →
Publication:
US 2024/0358766
Viable Bioengineered Allogeneic Cellularized Skin Constructs That Secrete Soluble Factors Associated with Regenerative Wound Healing
Application:
18/568,672 →
Publication:
US 2024/0207487
Related Assignments
(16)
Other recorded transfers of the patents in this record — the chain of ownership.
Notice of Grant of Security Interest in Patents
Sep 16, 2016
From: STRATATECH CORPORATION
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 040059/0222 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Conversion
Jan 22, 2020
From: SUCAMPO AG
To: SUCAMPO GMBH
Reel/Frame 051666/0768 →
Partial Assignment
Jan 23, 2020
From: R-TECH UENO, LTD.
To: SUCAMPO AG
Reel/Frame 051681/0987 →
Assignment of Assignor's Interest
Jan 23, 2020
From: UENO, RYUJI
To: R-TECH UENO, LTD.
Reel/Frame 051599/0266 →
Assignment of Assignor's Interest
Jan 23, 2020
From: HASHITERA, YUKIKO; HIRATA, RYU; HARADA, YASUHIRO
To: R-TECH UENO, LTD.
Reel/Frame 051599/0086 →
Conversion
Jan 27, 2020
From: SUCAMPO AG
To: SUCAMPO GMBH
Reel/Frame 051708/0596 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Release of Patent Security Interests Recorded at Reel 040059, Frame 0222
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0083 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Release of Security Interest
Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072324/0740 →
Security Interest
Oct 28, 2025
From: STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 072700/0001 →